NSEDCP
ASPX

NJ State Employees Deferred Compensation Plan’s AUSPEX PHARMACEUTICALS INC COM STK (DE) ASPX Stock Holding History

NJ State Employees Deferred Compensation Plan’s Portfolio ASPX Stock Details ASPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-6,600
Closed -$662K – 383
2015
Q1 		$662K Hold
6,600
– – 0.13% 261
2014
Q4 		$346K Buy
+6,600
New +$194K 0.07% 317
2014
Q2 		– Sell
-6,600
Closed -$204K – 390
2014
Q1 		$204K Buy
+6,600
New +$177K 0.04% 373

NJ State Employees Deferred Compensation Plan's ASPX Position: Q2 2015 in Review

NJ State Employees Deferred Compensation Plan sold out of AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) in Q2 2015, closing a stake of 6,600 shares — an estimated $662K sold.

NJ State Employees Deferred Compensation Plan first reported a position in ASPX in Q1 2014 and held it in 3 quarters. The position peaked at $662K in Q1 2015. 0 funds tracked by Wall St. Rank hold ASPX as of Q2 2015.

  • NJ State Employees Deferred Compensation Plan reported no remaining AUSPEX PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • NJ State Employees Deferred Compensation Plan sold 6,600 AUSPEX PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $662K.
  • NJ State Employees Deferred Compensation Plan first reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q1 2014 and held it in 3 quarters.
  • NJ State Employees Deferred Compensation Plan's AUSPEX PHARMACEUTICALS INC COM STK (DE) position peaked at $662K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held AUSPEX PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on NJ State Employees Deferred Compensation Plan's 13F filing for Q2 2015, filed 6 Aug 2015.